Daito Pharmaceutical Co.,Ltd.'s substantial shareholding report status has been updated, reflecting a change in the holdings of a major shareholder. As of 4 February 2026, Massachusetts Financial Services Company's stake had decreased to 3.91%, representing 1,177,100 shares.
A substantial shareholding report dated 4 February 2026 records that Massachusetts Financial Services Company's stake changed to 3.91%, with its shareholding changing to 1,177,100 shares. The update reflects the company's continuing position among Daito Pharmaceutical Co.,Ltd.'s major shareholders.
A corrected report dated 15 August 2025 states that Kaname Capital LP held a 11.13% stake, representing 3,351,200 shares. A separate change report dated 12 August 2025, filed on the same day, also stated a 11.13% stake, representing 3,351,100 shares.
A change report dated 6 June 2025 updated Kaname Capital LP's stake to 9.98%, representing 1,532,100 shares.
A change report dated 22 August 2024 also stated that Kaname Capital LP held a 9.98% stake, representing 1,532,100 shares.